{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:39:10Z","timestamp":1791722350508,"version":"4.3.4"},"reference-count":83,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0138803","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T14:12:20Z","timestamp":1444313540000},"page":"e0138803","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Monoconjugation of Human Amylin with Methylpolyethyleneglycol"],"prefix":"10.1371","volume":"10","author":[{"given":"Th\u00e1yna","family":"Sisnande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Henrique","family":"Guerreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel R.","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Jotha-Mattos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza C. S.","family":"Erthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Tinoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Maur\u00edcio T. R.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","article-title":"Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells","volume":"39","author":"SE Kahn","year":"1990","journal-title":"Diabetes"},{"key":"ref2","first-page":"E19","article-title":"Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets","volume":"276","author":"F Wang","year":"1999","journal-title":"Am J Physiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2362.2003.01142.x","article-title":"Inverse relation between amylin and glucagon secretion in healthy and diabetic human subjects","volume":"33","author":"B Ludvik","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0168-8227(92)90142-E","article-title":"Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin and glucose in the mouse","volume":"18","author":"G Panagiotidis","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-0115(02)00252-5","article-title":"Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets","volume":"111","author":"B Akesson","year":"2003","journal-title":"Regul Pept"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","article-title":"Dose-response for glucagonostatic effect of amylin in rats","volume":"46","author":"BR Gedulin","year":"1997","journal-title":"Metabolism"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.regpep.2006.06.004","article-title":"Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187","volume":"137","author":"BR Gedulin","year":"2006","journal-title":"Regul Pept"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S0001-37652013005000011","article-title":"Amylin induces hypoglycemia in mice","volume":"85","author":"L Guerreiro","year":"2013","journal-title":"An Acad Bras Cienc"},{"key":"ref9","first-page":"E6","article-title":"Amylin influences insulin-stimulated glucose metabolism by two independent mechanisms","volume":"274","author":"AL Castle","year":"1998","journal-title":"Am J Physiol"},{"key":"ref10","article-title":"Amylin: Physiology and Pharmacology","author":"A Young","year":"2005"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"GJ Cooper","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"P Westermark","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.5.5.527","article-title":"The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands oe langerhans","volume":"5","author":"EL Opie","year":"1901","journal-title":"J Exp Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"E1317","DOI":"10.1152\/ajpendo.00082.2006","article-title":"Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP","volume":"291","author":"JJ Meier","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s001250051295","article-title":"Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated islets","volume":"42","author":"DL MacArthur","year":"1999","journal-title":"Diabetologia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"AE Butler","year":"2003","journal-title":"Diabetes"},{"key":"ref17","first-page":"151","article-title":"Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes","volume":"9","author":"A Clark","year":"1988","journal-title":"Diabetes Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2337\/diabetes.52.9.2315","article-title":"An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures","volume":"52","author":"RG Bennett","year":"2003","journal-title":"Diabetes"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jms.3338","article-title":"The role of copper(II) and zinc(II) in the degradation of human and murine IAPP by insulin-degrading enzyme","volume":"49","author":"F Bellia","year":"2014","journal-title":"J Mass Spectrom"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jmb.2009.04.077","article-title":"Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes","volume":"389","author":"S Jha","year":"2009","journal-title":"J Mol Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"10971","DOI":"10.1021\/bi034889i","article-title":"The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies","volume":"42","author":"Y Porat","year":"2003","journal-title":"Biochemistry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1002\/anie.200602034","article-title":"Molecular mapping of the recognition interface between the islet amyloid polypeptide and insulin","volume":"45","author":"S Gilead","year":"2006","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1042\/bj20030852","article-title":"Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation","volume":"377","author":"ET Jaikaran","year":"2004","journal-title":"Biochem J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jmb.2003.10.045","article-title":"The mechanism of insulin action on islet amyloid polypeptide fiber formation","volume":"335","author":"JL Larson","year":"2004","journal-title":"J Mol Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bpc.2010.01.006","article-title":"Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin","volume":"150","author":"D Sellin","year":"2010","journal-title":"Biophys Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1110\/ps.036350.108","article-title":"Interaction of membrane-bound islet amyloid polypeptide with soluble and crystalline insulin","volume":"17","author":"JD Knight","year":"2008","journal-title":"Protein Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/anie.201105877","article-title":"Cross-amyloid interaction of Abeta and IAPP at lipid membranes","volume":"51","author":"J Seeliger","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jmb.2011.05.015","article-title":"A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc","volume":"410","author":"S Salamekh","year":"2011","journal-title":"J Mol Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.febslet.2007.06.061","article-title":"Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type\u20132 diabetes mellitus?","volume":"581","author":"A Masad","year":"2007","journal-title":"FEBS Lett"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jinorgbio.2007.09.010","article-title":"Copper(II) inhibits the formation of amylin amyloid in vitro","volume":"102","author":"B Ward","year":"2008","journal-title":"J Inorg Biochem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3923\/pjbs.2011.288.292","article-title":"Evaluation of aluminium, manganese, copper and selenium effects on human islets amyloid polypeptide hormone aggregation","volume":"14","author":"SM Mirhashemi","year":"2011","journal-title":"Pak J Biol Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/diacare.25.2.292","article-title":"Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes","volume":"25","author":"NG Knowles","year":"2002","journal-title":"Diabetes Care"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"SE Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0306-9877(91)90150-W","article-title":"Amylin and insulin co-replacement therapy for insulin-dependent (type I) diabetes mellitus","volume":"36","author":"GJ Cooper","year":"1991","journal-title":"Med Hypotheses"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.26.3.784","article-title":"Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial","volume":"26","author":"PA Hollander","year":"2003","journal-title":"Diabetes Care"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.2337\/dc07-0589","article-title":"Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin","volume":"30","author":"M Riddle","year":"2007","journal-title":"Diabetes Care"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/dc06-1026","article-title":"Effect of adjunctive pramlintide treatment on treatment satisfaction in patients with type 1 diabetes","volume":"30","author":"DG Marrero","year":"2007","journal-title":"Diabetes Care"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0026-0495(99)90232-9","article-title":"The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus","volume":"48","author":"B Nyholm","year":"1999","journal-title":"Metabolism"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2337\/dc14-1140","article-title":"Type 1 diabetes through the life span: a position statement of the American Diabetes Association","volume":"37","author":"JL Chiang","year":"2014","journal-title":"Diabetes Care"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"R1475","DOI":"10.1152\/ajpregu.00703.2009","article-title":"The role of amylin in the control of energy homeostasis","volume":"298","author":"TA Lutz","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref41","first-page":"E457","article-title":"Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro","volume":"259","author":"DA Young","year":"1990","journal-title":"Am J Physiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"36621","DOI":"10.1074\/jbc.M006170200","article-title":"Degradation of amylin by insulin-degrading enzyme","volume":"275","author":"RG Bennett","year":"2000","journal-title":"J Biol Chem"},{"key":"ref43","first-page":"E903","article-title":"Distribution and kinetics of amylin in humans","volume":"274","author":"M Clodi","year":"1998","journal-title":"Am J Physiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2337\/db12-1326","article-title":"beta-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?","volume":"62","author":"S Costes","year":"2013","journal-title":"Diabetes"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1073\/pnas.85.20.7763","article-title":"Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle","volume":"85","author":"GJ Cooper","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"P Westermark","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bpc.2013.07.013","article-title":"Stepwise oligomerization of murine amylin and assembly of amyloid fibrils","volume":"180\u2013181","author":"LC Palmieri","year":"2013","journal-title":"Biophys Chem"},{"key":"ref48","first-page":"118","article-title":"Pramlintide. AC 137, ACO 137, Normylin, Symlin, Tripro-amylin","volume":"2","year":"1999","journal-title":"Drugs R D"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M","article-title":"Preclinical Pharmacology of Pramlintide in the rat: comparisons with human and rat amylin","volume":"37","author":"AA Young","year":"1996","journal-title":"Drug Development Research"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1463-1326.2010.01201.x","article-title":"Safety of pramlintide added to mealtime insulin in patients with type 1 or type 2 diabetes: a large observational study","volume":"12","author":"R Pencek","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1517\/14656566.2011.581663","article-title":"Pramlintide and the treatment of diabetes: a review of the data since its introduction","volume":"12","author":"LM Younk","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"ref52","unstructured":"Amylin Pharmaceuticals (2000) NDA 21\u2013332\u2014Division of Pharmaceutical Evaluation-II Office of Clinical Pharmacology and Biopharmaceutics\u2014Symlin. 1\u201334."},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1021\/bi802097b","article-title":"Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin","volume":"48","author":"L Wei","year":"2009","journal-title":"Biochemistry"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"10176","DOI":"10.1021\/jp101811u","article-title":"pH-Dependent interactions of human islet amyloid polypeptide segments with insulin studied by replica exchange molecular dynamics simulations","volume":"114","author":"P Jiang","year":"2010","journal-title":"J Phys Chem B"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.colsurfb.2012.01.021","article-title":"Polymeric particles for the controlled release of human amylin","volume":"94","author":"LH Guerreiro","year":"2012","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref56","article-title":"Preparation and Characterization of PEGylated Amylin","author":"LH Guerreiro","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"ref57","first-page":"113","article-title":"PEGylated Protein Drugs: Basic Science and Clinical Applications","author":"CJ Fee","year":"2009"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"UK Laemmli","year":"1970","journal-title":"Nature"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpharm.2010.03.036","article-title":"Biochemical and biophysical characterization of lysozyme modified by PEGylation","volume":"392","author":"DS Freitas","year":"2010","journal-title":"International Journal of Pharmaceutics"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jconrel.2012.06.026","article-title":"A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization","volume":"164","author":"S Scaramuzza","year":"2012","journal-title":"J Control Release"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"CA Schneider","year":"2012","journal-title":"Nature Methods"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.178.4063.871","article-title":"Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range","volume":"178","author":"S Udenfriend","year":"1972","journal-title":"Science"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/rcm.3444","article-title":"mMass data miner: an open source alternative for mass spectrometric data analysis","volume":"22","author":"M Strohalm","year":"2008","journal-title":"Rapid Communications in Mass Spectrometry"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"16284","DOI":"10.1021\/bi051432v","article-title":"The role of His\u201318 in amyloid formation by human islet amyloid polypeptide","volume":"44","author":"A Abedini","year":"2005","journal-title":"Biochemistry"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1021\/bi002555c","article-title":"Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism","volume":"40","author":"L Nielsen","year":"2001","journal-title":"Biochemistry"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.micron.2012.07.001","article-title":"Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide","volume":"44","author":"NG Milton","year":"2013","journal-title":"Micron"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1006\/jmbi.1999.3286","article-title":"Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin","volume":"294","author":"MR Nilsson","year":"1999","journal-title":"J Mol Biol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/abio.2000.4887","article-title":"Synthesis and purification of amyloidogenic peptides","volume":"288","author":"MR Nilsson","year":"2001","journal-title":"Analyt Biochem"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jconrel.2011.10.037","article-title":"State of the art in PEGylation: The great versatility achieved after forty years of research","volume":"161","author":"G Pasut","year":"2012","journal-title":"J Control Release"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ab.2005.11.029","article-title":"Recovery and purification of highly aggregation-prone disulfide-containing peptides: application to islet amyloid polypeptide","volume":"351","author":"A Abedini","year":"2006","journal-title":"Analyt Biochem"},{"key":"ref71","article-title":"Amylin Conjugation with Methoxyl Polyethyleneglycol","author":"MF Guterres","year":"2013","journal-title":"Protein Pept Lett"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1677\/joe.0.1550423","article-title":"Coexistence of novel amylin-binding sites with calcitonin receptors in human breast carcinoma MCF\u20137 cells","volume":"155","author":"U Zimmermann","year":"1997","journal-title":"J Endocrinol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1124\/mol.52.6.1164","article-title":"Expression cloning and receptor pharmacology of human calcitonin receptors from MCF\u20137 cells and their relationship to amylin receptors","volume":"52","author":"WJ Chen","year":"1997","journal-title":"Mol Pharmacol"},{"key":"ref74","first-page":"808","article-title":"The Treatment of Diabetes Mellitus","volume":"14","author":"EP Joslin","year":"1924","journal-title":"Can Med Assoc J"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"S Zoungas","year":"2010","journal-title":"N Engl J Med"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"721","DOI":"10.5694\/j.1326-5377.1993.tb141332.x","article-title":"The Diabetes Control and Complications Trial (DCCT). A milestone in diabetes management","volume":"159","author":"DJ Chrisholm","year":"1993","journal-title":"Med J Aust"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9343(91)80085-Z","article-title":"Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group","volume":"90","year":"1991","journal-title":"Am J Med"},{"key":"ref78","article-title":"Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study","author":"ER Fahrmann","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0145721711403011","article-title":"Primer on pramlintide, an amylin analog","volume":"37","author":"AN Traina","year":"2011","journal-title":"Diabetes Educ"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajhp\/62.8.816","article-title":"Properties of pramlintide and insulin upon mixing","volume":"62","author":"C Weyer","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"ref81","unstructured":"Amylin Pharmaceuticals (2015) Symlin (R) Pramlintide Acetate Injection\u2014Leaflet NDA 21\u2013332. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.accessdata.fda.gov\/\" xlink:type=\"simple\">http:\/\/www.accessdata.fda.gov\/<\/ext-link> 1\u201347."},{"key":"ref82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/1520-6017(200101)90:1<29::AID-JPS4>3.0.CO;2-4","article-title":"Studies of the structure of insulin fibrils by Fourier transform infrared (FTIR) spectroscopy and electron microscopy","volume":"90","author":"L Nielsen","year":"2001","journal-title":"J Pharm Sci"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jmb.2005.09.100","article-title":"The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting","volume":"355","author":"JS Pedersen","year":"2006","journal-title":"J Mol Biol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0138803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T05:46:02Z","timestamp":1567230362000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0138803"}},"subtitle":[],"editor":[{"given":"Christian","family":"Holscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":83,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0138803","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]}}}